
Ekzone S 1000mg/500mg Injection
Marketer
Ekansh Pharma
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Ekzone S 1000mg/500mg Injection
Combiflox 1000mg/500mg Injection is a dual-action antibiotic indicated for diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection progression. Administration of Combiflox 1000mg/500mg Injection requires strict medical oversight. Adherence to the prescribed regimen is crucial; premature cessation may compromise efficacy. Complete the full course of treatment, even with symptom improvement. Typical mild reactions may include nausea, vomiting, diarrhea, or dyspepsia. Severe side effects necessitate immediate medical attention. Allergic responses (skin rashes, itching, swelling, respiratory distress) demand prompt medical help. Inform your physician of all current medications before commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, avoid operation of vehicles if drowsiness or dizziness occurs. Adequate rest, nutritious food, and hydration support optimal recovery. Your doctor might order laboratory tests to monitor treatment response.
Primary Ingredients of Ekzone S 1000mg/500mg Injection
No text provided. Please provide the text you wish me to rewrite.
Uses of Ekzone S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Ekzone S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Ekzone S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Ekzone S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Ekzone S 1000mg/500mg Injection works:
Ceftriaxone and Sulbactam, combined as Ekzone S 1000mg/500mg Injection, offer a dual-action approach to bacterial infection. Ceftriaxone, a cephalosporin antibiotic, disrupts bacterial cell wall synthesis, hindering their growth and survival. Sulbactam, a beta-lactamase inhibitor, counters bacterial resistance mechanisms, thereby boosting Ceftriaxone's effectiveness.
SAFETY ADVICE
AlcoholSAFE
The concomitant use of alcohol and Ekzone S 1000mg/500mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Ekzone S (1000mg/500mg) is typically deemed safe for use during gestation. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, clinical data from human trials remain scarce.
Breast feedingCAUTION
The administration of Ekzone S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Mothers should discontinue breastfeeding for the duration of treatment and until the medication is fully cleared from their system.
DrivingUNSAFE
Administering Ekzone S 1000mg/500mg Injection might induce drowsiness, blurred vision, or dizziness. Refrain from operating a vehicle if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Ekzone S 1000mg/500mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
Patients with severe hepatic impairment should receive Ekzone S 1000mg/500mg Injection cautiously, with potential dose modifications as clinically indicated. Consult a physician for appropriate dosage. Dosage alterations for Ekzone S 1000mg/500mg Injection are unnecessary in individuals exhibiting mild to moderate liver dysfunction.
What if you forget to take Ekzone S 1000mg/500mg Injection :
Should you inadvertently skip a dose of Ekzone S 1000mg/500mg Injection, seek medical advice.
Facts to Know About Ekzone S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-Infective Agents |
